Healsun Biopharm is a pharmaceutical company.
Healsun Biopharm is a pharmaceutical company development processes such as molecular construction, stable cell line screening, cell culture process development, protein purification and process development, antibody-coupled drug process development and bioanalytical method development.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 19, 2022 | Series B | ¥250M | 3 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Orient Jiafu Asset Management | — | Series B |
Xinghua Dingli | — | Series B |
HT Capital | — | Series B |